Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-17

Clinical Trial Update: BRAVO: Background Regimen of Raltegravir on Virologic Outcome

View source ↗

Summary

Clinical trial BRAVO studied a background regimen including raltegravir for HIV; the trial is completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isentress (Raltegravir)

Snippet

Sponsor: Community Research Initiative of New England | Conditions: HIV Infections | Status: COMPLETED | Results posted: 2011-06-17